000 01408 a2200349 4500
005 20250518035934.0
264 0 _c20190718
008 201907s 0 0 eng d
022 _a1129-2377
024 7 _a10.1186/s10194-019-1000-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTiseo, Cindy
245 0 0 _aHow to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice.
_h[electronic resource]
260 _bThe journal of headache and pain
_cMay 2019
300 _a49 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aCalcitonin Gene-Related Peptide
_xmetabolism
650 0 4 _aCalcitonin Gene-Related Peptide Receptor Antagonists
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aHumans
650 0 4 _aMigraine Disorders
_xdrug therapy
650 0 4 _aPublic Health
_xmethods
650 0 4 _aQuality of Life
_xpsychology
650 0 4 _aReceptors, Calcitonin Gene-Related Peptide
_xmetabolism
700 1 _aOrnello, Raffaele
700 1 _aPistoia, Francesca
700 1 _aSacco, Simona
773 0 _tThe journal of headache and pain
_gvol. 20
_gno. 1
_gp. 49
856 4 0 _uhttps://doi.org/10.1186/s10194-019-1000-5
_zAvailable from publisher's website
999 _c29662685
_d29662685